Skip to search boxSkip to navigationSkip to main content

Therapeutic potential of FGF21 in cardiorenal syndrome

  • Fanghua Li
    ,
  • Chengyuan Tang
    ,
  • Zheng Dong(corresponding author)
*Corresponding author for this work
Scholary Output:
Contribution to journal
Article
 Peer-review

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
 Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 70-71 (2 pages)

Journal (Volume, Issue Number)

International Journal of Cardiology (Volume 214)

Publication milestones

  • Published - 07/01/2016

Publication status

Published - 07/01/2016

ISSN

0167-5273

Publication IDs

  • Scopus: 84964043502
  • PubMed: 27057978

Access to documents

Publication metrics

Metrics

SciVal
citations
1
SciVal
FWCI
0.11
SciVal
Author count
3
SciVal
Paper percentile
34
Scopus
citations
1, opens in new tab
Fractional count
1
Fractional count
0.33
Fractional count
2
Fractional count
0.67
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Citation count
1
Captures
7

Funding Details

The study was supported in part by grants from the National Natural Science Foundation of China [ 81430017 ], National Basic Research Program of China 973 Program No. 2012CB517601 , and the National Institutes of Health ( DK058831 ) and Department of Veterans Administration of USA.
FundersFunding numbers
Administration Medical Center
-
NIH
DK058831
NSFC
81430017, 2012CB517601